ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for: Accord

What was recalled

The U.S. Food and Drug Administration (FDA) has issued a Class II recall involving a specific batch of prescription medication manufactured by Accord Healthcare, Inc. This regulatory action centers on Levothyroxine Sodium Tablets, USP, specifically in the 112 mcg (0.112 mg) strength. It is important to understand that this is not a broad recall affecting all versions of this drug or even all products made by this company. Instead, it targets a very precise set of circumstances involving quantity, packaging, and manufacturing origin.

The affected products are Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), packaged in large, 1000-count bottles. These are prescription-only medications, indicated by the "Rx Only" labeling found on the packaging. The National Drug Code (NDC) for these specific bottles is 16729-452-17. This unique identifier is your primary tool for verifying whether a bottle in your possession is part of this recall. If you have a bottle with this NDC, you must check the lot number and expiration date to confirm if it falls within the recalled range.

The manufacturing details are crucial for identifying the affected units. These tablets were manufactured by Intas Pharmaceuticals Limited, located at Camp Road, Selaqui, Dehradun-248 197, India, for Accord Healthcare, Inc., which is based in Raleigh, North Carolina (zip code 27617). The recall applies to three specific lots: D2402443, D2402444, and D2402445. All of these lots share an expiration date of October 31, 2026. If your bottle has a different lot number or a different expiration date, it is not part of this specific recall action.

The scope of the distribution was nationwide within the United States. This means that any pharmacy, hospital, or medical facility across the country could potentially have dispensed these bottles. The recall was officially announced on August 6, 2026. Because these are large 1000-count bottles, they are typically distributed to institutional settings, long-term care facilities, or large wholesale distributors rather than individual retail pharmacies for direct consumer pickup. However, because the distribution was nationwide, it is essential for anyone who manages medication inventory or has recently filled a prescription for this specific strength and lot number to verify their stock immediately.

Understanding exactly what was recalled helps prevent unnecessary panic while ensuring that affected individuals take appropriate action. The key identifiers are the NDC 16729-452-17, the lot numbers D2402443, D2402444, or D2402445, and the expiration date of 10/31/2026. If your medication matches all these criteria, it is part of the recall. If any detail differs, it is not affected by this specific FDA action.

The hazard, explained

When we talk about a "subpotent" drug recall, it can sound like abstract regulatory jargon, but the reality is quite physical and direct. In plain terms, subpotent means that the medication contains less of the active ingredient than what is printed on the label. For the Levothyroxine Sodium Tablets recalled by Accord Healthcare, Inc., the label claims a strength of 112 mcg (0.112 mg). However, testing has revealed that the actual amount of levothyroxine sodium inside these specific bottles is lower than that stated amount. This is not a matter of the pill being slightly weaker due to natural variation; it is a significant deviation where the medication simply cannot do the job it was designed to do.

To understand why this matters, we have to look at what levothyroxine actually does in your body. Levothyroxine is a synthetic version of thyroxine (T4), a hormone naturally produced by your thyroid gland. This hormone is the master regulator of your metabolism. It controls how fast your body burns energy, how your heart beats, and even how your brain functions. Unlike many other medications where missing a dose or taking a slightly lower dose might just mean you feel a bit off for a day, thyroid hormone replacement requires precise, consistent dosing. Your body relies on a very narrow window of hormone levels to function correctly. When the drug is subpotent, it creates a gap between what your body needs and what it receives.

The physical mechanism of harm here is subtle but cumulative. Because the tablets contain less active ingredient than promised, your thyroid-stimulating hormone (TSH) levels will likely rise as your body struggles to compensate for the lack of thyroid hormone. This state is known as hypothyroidism or a worsening of existing hypothyroidism. You might not notice this immediately because thyroid symptoms often develop slowly. Over time, however, the lack of sufficient hormone can lead to a significant slowing of bodily functions. This isn't just about feeling tired; it affects your heart rate, your cholesterol levels, your body temperature regulation, and your mental clarity.

The danger is particularly acute because the discrepancy is hidden. You cannot see, smell, or taste that a pill is subpotent. It looks exactly like the correct medication. This means that patients who depend on this specific dosage to manage their thyroid conditions are unknowingly under-treated. For individuals with heart conditions, where precise thyroid levels are critical for maintaining stable cardiac function, this unexpected drop in hormone potency can introduce serious risks. The harm doesn't come from a toxic reaction, but from an absence of necessary support—a silent under-dosing that leaves your body’s vital systems running without their full fuel.

In summary, the hazard is one of reliability and efficacy. The drug fails to deliver the therapeutic effect promised on the box. For millions of people who rely on levothyroxine to maintain a normal quality of life, this recall represents a break in that chain of trust. It underscores why regulatory agencies like the FDA monitor manufacturing processes so closely: because when a hormone replacement is weak, the consequences are felt throughout every system in your body.

Who is most at risk

The primary group affected by this recall consists of patients who have been prescribed Levothyroxine Sodium Tablets, USP, specifically in the 112 mcg (0.112 mg) strength. Because this medication is dispensed exclusively in large, 1000-count bottles under a "Rx Only" designation, it is typically not found in individual patient homes but rather distributed to long-term care facilities, hospitals, or specialized pharmacies that manage high-volume prescriptions for chronic conditions. Consequently, the individuals most immediately at risk are those residing in nursing homes, assisted living facilities, or other institutional settings where Accord Healthcare’s products are routinely utilized for daily medication management.

Levothyroxine is a synthetic form of thyroxine, a critical hormone produced by the thyroid gland that regulates metabolism, energy levels, and heart function. For many patients, particularly the elderly, this drug is not merely a supplement but a life-sustaining treatment for hypothyroidism—a condition where the thyroid gland does not produce enough hormones. The 112 mcg dosage is often prescribed to adults who require precise hormonal balancing. When a drug is subpotent, meaning it contains less of the active ingredient than labeled, the body does not receive the necessary hormonal support. For these patients, the risk is not abstract; it is physiological and immediate.

Elderly individuals are arguably the most vulnerable demographic in this scenario. As people age, their bodies become more sensitive to fluctuations in hormone levels, and they often have comorbidities that complicate thyroid management. A sudden drop in effective thyroid hormone levels can lead to symptoms such as severe fatigue, cold intolerance, constipation, and dry skin. However, the dangers extend far beyond discomfort. In older adults, untreated or under-treated hypothyroidism can precipitate more serious cardiovascular issues, including bradycardia (an abnormally slow heart rate) and elevated cholesterol levels, which increase the risk of heart disease. Because the elderly often have reduced physiological reserve, their bodies may struggle to compensate for even minor hormonal deficits, making them susceptible to rapid clinical deterioration.

Furthermore, patients who rely on this specific lot number (D2402443, D2402444, or D2402445) with an expiration date of October 31, 2026, are at risk because the subpotency may not be immediately apparent. Unlike antibiotics where efficacy drops can lead to treatment failure and infection spread, thyroid hormone imbalances develop gradually. A patient might feel "slightly off" for weeks before realizing their medication is the cause. This insidious onset is particularly dangerous for individuals who rely on stable thyroid levels to maintain cognitive clarity and physical mobility. Without prompt intervention, prolonged exposure to subpotent Levothyroxine can lead to myxedema, a rare but potentially life-threatening condition characterized by extreme weakness, confusion, and hypothermia. Therefore, anyone in an institutional setting or with a chronic prescription history who has received these specific bottles from Accord Healthcare should consider their medication status urgent.

How to tell if you have the recalled item

If you are taking Levothyroxine Sodium for thyroid management, verifying whether your current supply is part of this specific recall is a straightforward process that requires checking two distinct areas of your medication bottle. Because this recall involves a Class II classification due to the drug being subpotent—meaning it may not deliver the full strength of hormone your body expects—it is critical to confirm the exact lot numbers before making any changes to your regimen. The FDA has identified specific batches from Accord Healthcare, Inc., and knowing exactly what to look for will save you time and prevent unnecessary worry.

First, locate the vertical label on the side of your 1000-count bottle. This label contains the National Drug Code (NDC), which serves as a unique identifier for the product. For this recall, you are looking for NDC 16729-452-17. This code confirms that the medication was manufactured for Accord Healthcare, Inc., based in Raleigh, North Carolina. It is important to note that while Accord is the company distributing the drug, the actual manufacturing took place at Intas Pharmaceuticals Limited in Selaqui, Dehradun, India. If your bottle does not match this specific NDC, it is not part of this particular recall event.

The most critical step in identification is checking the lot number and expiration date, which are typically printed together on the same vertical label or clearly visible on the front/side panel. You must look for one of the following three lot numbers: D2402443, D2402444, or D2402445. If your bottle displays any of these codes, it is part of the recalled inventory. Additionally, verify that the expiration date listed on the bottle is 10/31/2026. The combination of the specific NDC and any of the three listed lot numbers confirms that your medication is affected by this recall.

When inspecting your bottle, ensure you are looking at the correct dosage strength. This recall specifically applies to Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg). These tablets are prescription-only ("Rx Only") and come in large 1000-count bottles. If you have a different strength, such as 50 mcg or 75 mcg, or if your bottle contains fewer than 1000 tablets, it is not included in this recall notice. Since the distribution pattern for these items was nationwide within the United States, the location where you purchased the medication does not determine its inclusion; only the physical identifiers on the bottle matter.

If you have confirmed that your bottle matches the NDC 16729-452-17 and one of the listed lot numbers with an expiration date of 10/31/2026, do not stop taking your medication abruptly. Subpotent drugs can lead to serious health issues if dosage is inconsistent without medical supervision. Instead, contact your pharmacist or healthcare provider immediately with this information. They can help you verify the recall status in their system and guide you through the process of obtaining a replacement or alternative treatment. Your pharmacist will also be able to provide details on any potential refunds or exchanges offered by Accord Healthcare, Inc., as the remedy for this specific recall was not explicitly stated in the initial FDA report.

What to do — step by step

If you have been prescribed Levothyroxine Sodium Tablets by Accord Healthcare, specifically the 112 mcg (0.112 mg) strength found in 1000-count bottles, it is crucial that you take immediate action to protect your health. Because this recall involves a subpotent drug, the medication may not contain enough of the active ingredient to effectively manage thyroid hormone levels in your body. While the official FDA recall announcement does not specify a detailed remedy or return procedure for consumers, the nature of this hazard requires you to prioritize your medical continuity above all else. Please follow these steps carefully.

1. Do not stop taking your medication abruptly. Levothyroxine is a hormone replacement therapy that regulates your metabolism, energy levels, and heart function. Stopping it suddenly can lead to serious health complications, including severe fatigue, weight gain, and even myxedema coma in extreme cases. Instead of discontinuing use on your own, you must contact your prescribing healthcare provider or pharmacist immediately. They need to know about the recall so they can evaluate your specific medical history and determine the safest transition plan.
2. Contact your pharmacy and doctor right away. When you speak with your pharmacist, provide them with the specific details of the bottle you have: NDC 16729-452-17, Lot numbers D2402443, D2402444, or D2402445, and an expiration date of 10/31/2026. Your pharmacist can verify if your specific fill was part of this batch. More importantly, they can help you locate a different manufacturer’s version of Levothyroxine Sodium that is not affected by this recall. It is vital to switch to a verified, non-recalled source to ensure you continue receiving the correct dosage.
3. Hold onto the recalled medication for now. Do not throw the pills in the trash or flush them down the toilet yet. Keep the bottle sealed and stored safely out of reach of children and pets. Since the recall facts do not state a specific return address or mail-in process, you should wait for further instructions from your pharmacist or the manufacturer, Accord Healthcare, Inc. If you need to dispose of the medication later, most pharmacies offer safe take-back programs that prevent environmental contamination.
4. Monitor your health closely. Because the drug is subpotent, you may experience symptoms of hypothyroidism, such as unusual tiredness, sensitivity to cold, dry skin, or mood changes. Keep a log of any new or worsening symptoms and share this with your doctor during your next appointment. They may recommend blood tests to check your thyroid-stimulating hormone (TSH) levels to ensure your new medication is working effectively.
5. Report any adverse effects. If you have experienced any health issues while taking these tablets, report them to the FDA’s MedWatch program. This helps authorities track the impact of the recall and ensures that other patients are aware of potential risks. You can do this online at the FDA website or by calling their safety hotline.

Remember, the goal here is to maintain your health without interruption. By acting quickly and communicating with your healthcare team, you can navigate this recall safely and effectively.

Your refund, repair, or replacement options

When a pharmaceutical recall occurs, particularly one involving a medication that manages a chronic condition like thyroid health, the immediate question is often, "What happens to the pills I already have?" In this specific case involving Accord Healthcare, Inc.’s Levothyroxine Sodium Tablets, 112 mcg, the situation requires careful attention because the recall notice does not explicitly outline a standard consumer remedy such as a direct mail-in refund or a prepaid return label. This absence of stated remediation instructions is a critical detail that distinguishes this recall from others where companies proactively handle all logistics. Instead, the path forward relies on leveraging your existing healthcare relationships rather than navigating a complex return process yourself.

The primary and most effective step you should take is to contact the pharmacist who filled your prescription. Pharmacists are trained to manage inventory issues and recall notifications daily. They have direct lines of communication with the distributor and the manufacturer, Accord Healthcare, Inc., based in Raleigh, North Carolina. When you call or visit your pharmacy, they can verify if your specific stock comes from the affected lots (D2402443, D2402444, or D2402445) and advise you on the next steps. In many cases, pharmacies will coordinate with their wholesalers to remove the product from their shelves and replace it with a non-recalled lot or an alternative therapeutic option that is safe for you to use immediately.

If you have purchased this medication directly from a retailer rather than via prescription, your approach should shift to customer service. Check your receipt or the packaging for any customer service numbers associated with Accord Healthcare, Inc. Since the recall facts do not provide a specific phone number or website for consumer complaints or returns, you will need to locate these details through the manufacturer’s official public channels or the retailer where you made the purchase. Do not attempt to ship the product back without explicit authorization, as this can create logistical and safety hazards.

It is also important to understand that "repair" is not an applicable remedy for medication. You cannot fix subpotent drugs; they must be disposed of safely. Therefore, your "replacement" option is essentially a new prescription or a new purchase from a safe source. If you are concerned about having received a refund for the cost of the medication, this is typically handled between the retailer and the manufacturer. However, because the remedy is not stated in the official FDA report, you should ask your pharmacy or retailer directly if they are offering any compensation for the inconvenience. Until you have confirmation from a healthcare professional that it is safe to continue using your current supply, do not take the medication. Your health and safety depend on ensuring you are receiving a dose that accurately matches what your doctor prescribed.

What can happen if you ignore it

Staying safe: broader tips

When we talk about medications like levothyroxine, safety isn’t just about avoiding a single recalled batch; it is about building a reliable system for managing your health over time. Levothyroxine is a synthetic form of thyroid hormone that helps regulate your metabolism, energy levels, and heart rate. Because the thyroid gland plays such a central role in how your body functions, consistency is everything. Even small variations in the amount of active ingredient you receive can lead to noticeable changes in how you feel, ranging from fatigue and weight gain to anxiety or heart palpitations. This is why understanding how to protect yourself from inconsistent medication quality is so important for long-term well-being.

One of the most effective ways to stay safe is to maintain open communication with your pharmacist. Pharmacists are not just dispensers of pills; they are trained healthcare professionals who monitor drug interactions and supply chain changes. If you ever notice that your new prescription looks different in color, shape, or size compared to what you have been taking, do not assume it is just a routine manufacturer change without checking. Ask your pharmacist to verify the National Drug Code (NDC) on the bottle against your previous fill. They can confirm if the manufacturer has switched suppliers and ensure that the medication is potent and effective. This simple question can prevent confusion and ensure you are getting the exact treatment your doctor prescribed.

Another crucial step in staying safe is to register for recall alerts directly from government sources. The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) provide free, reliable tools to help consumers stay informed. By signing up for email notifications on FDA.gov, you can receive immediate updates about safety recalls, whether they involve prescription drugs, over-the-counter medicines, or medical devices. This proactive approach means you do not have to rely on hearing about a problem from friends or social media; you will be among the first to know if a specific product needs to be returned or replaced. It turns passive consumption into active health management.

Finally, consider establishing a routine for monitoring your own health markers. If you take thyroid medication, regular blood tests are essential not just to confirm the dosage is correct, but to ensure that every bottle you fill is working as intended. If you feel sudden, unexplained changes in your mood, energy, or physical symptoms after switching pharmacies or receiving a new batch of medication, reach out to your healthcare provider promptly. These broader habits—verifying your medication, subscribing to official alerts, and monitoring your body’s response—create a strong shield around your health, ensuring that you remain protected regardless of what happens in the supply chain.